The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index; 38 of the 138 sources its claims cite were checked for support.
Speech and language markers of neurodegeneration: a call for global equity
Open accessAbstract
In the field of neurodegeneration, speech and language assessments are useful for diagnosing aphasic syndromes and for characterizing other disorders. As a complement to classic tests, scalable and low-cost digital tools can capture relevant anomalies automatically, potentially supporting the quest for globally equitable markers of brain health. However, this promise remains unfulfilled due to limited linguistic diversity in scientific works and clinical instruments. Here we argue for cross-linguistic research as a core strategy to counter this problem. First, we survey the contributions of linguistic assessments in the study of primary progressive aphasia and the three most prevalent neurodegenerative disorders worldwide—Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia. Second, we address two forms of linguistic unfairness in the literature: the neglect of most of the world’s 7000 languages and the preponderance of English-speaking cohorts. Third, we review studies showing that linguistic dysfunctions in a given disorder may vary depending on the patient’s language and that English speakers offer a suboptimal benchmark for other language groups. Finally, we highlight different approaches, tools and initiatives for cross-linguistic research, identifying core challenges for their deployment. Overall, we seek to inspire timely actions to counter a looming source of inequity in behavioural neurology.
Overview
CoChat Summary
## TL;DR
This paper is a perspective arguing that speech and language markers of neurodegeneration are promising but currently biased toward English and other high-income-language contexts. The authors call for cross-linguistic, cross-cultural research and shared tools to avoid turning “equitable” digital markers into a new source of global inequity.
## Key findings
- Speech and language assessments are presented as useful for diagnosing and monitoring primary progressive aphasia, Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia, with automated speech and language analysis (ASLA) highlighted as scalable and low-cost.
- The paper states that English is spoken to some proficiency by only 17% of the world’s population, yet dominates the literature; systematic reviews cited here report that speech/language studies span fewer than 20 languages overall, most in only a handful of papers.
- Reported language-specific findings include:
- In non-fluent/agrammatic PPA, English speakers showed more speech distortions, while Italian speakers showed distinct syntactic alterations.
- In semantic variant PPA, surface dysgraphia is common in English-speaking patients but not in Chinese-speaking patients, whose errors are described as involving homophones.
- In logopenic variant PPA, sentence repetition deficits were said to be more frequent in German than in English speakers.
- In Alzheimer’s disease, language effects differed across English, French, Italian, Bengali, and Chinese cohorts, including differences in feature importance, subject omission, pronoun use, and reading impairment.
- The authors note that some existing tools already span multiple languages, including the Comprehensive Aphasia Test in 13 languages, the Quick Aphasia Battery in 6 languages, and the Mini Linguistic State Examination validated in Spanish and Italian.
## Methods
- Perspective/commentary article: the authors synthesize prior studies and reviews rather than reporting a new empirical sample.
- The paper surveys evidence across primary progressive aphasia, Alzheimer’s disease, Parkinson’s disease, and behavioural variant frontotemporal dementia, emphasizing cross-linguistic comparisons.
- The main analysis is a narrative review of published and emerging cross-linguistic tools, findings, and implementation challenges, illustrated with figures and tables summarizing language distribution and disorder-specific markers.
## Limitations
- The paper itself notes that evidence is still limited, especially for behavioural variant frontotemporal dementia, for which it says no cross-linguistic studies have been performed to the authors’ knowledge.
- It states that validated tools are unavailable for most languages, and that many existing tests rely on translations rather than true cultural/linguistic adaptation.
- Evident from the text: this is a call for action rather than an original study, so its conclusions depend on the quality and scope of the cited literature rather than on new data collected here.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
20 Valid · 2 Not valid · 37 Not checked · 12 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“However, recent works underscore the broad clinical utility of speech and language testing in these 4,6 and other 140 neurodegenerative disor ders, even if many deficits are secondary to broader motoric or cogni tive dysfunction.”
What the sources say
- Not checked yetcites [4] Birba, 2017, Losing ground: Frontostriatal atrophy disrupts language embodiment in Parkinson's and huntington's disease, Neuroscience & Biobehavioral Reviews source
- Partly supportedcites [6] Geraudie, 2021, Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review, Neurosci Biobehav Rev sourceExperimental — accuracy not yet measured
The review does underscore clinical utility of speech and language testing, but in bvFTD specifically and with hedges: the Discussion ('Beyond the characterization of patients', differential-diagnosis paragraph) says 'a detailed language investigation seems to allow distinctions between bvFTD and other neurodegenerative disorders', and the Abstract/Discussion conclude impairments 'contribute to patient characterization and phenotyping, while potentially informing diagnosis and management' and 'could represent sensitive biomarkers'. The citing sentence states this as 'broad clinical utility' across other neurodegenerative disorders, which is stronger and wider than the source's hedged, bvFTD-centred claim. The clause that 'many deficits are secondary to broader motoric or cognitive dysfunction' is not supported: the Abstract attributes deficits to 'the disease's core neural disruptions' and the Introduction states that in bvFTD speech and language symptoms 'go beyond executive dysfunction' (citing Hardy et al., 2016); the closest the paper comes is the association that 'a more severe global cognitive impairment leads to more alterations in speech and language' (Discussion, 'The heterogeneity of language impairments in bvFTD'). (LLM, conf=0.75)
- Disputedcites [140] Suárez-González, 2021, When it is not primary progressive aphasia: A scoping review of spoken language impairment in other neurodegenerative dementias, Alzheimers Dement sourceExperimental — accuracy not yet measured
The source's central finding runs against the attributed point: the DISCUSSION states 'The clinical significance of these language deficits was not reported across studies (i.e., their impact on the quality of life or activities of daily living of the patients)', and Research question 2 adds that 'no studies directly measured the impact of language difficulties on activities of daily living or quality of life' and that suitable tools are lacking; the CONCLUSIONS/Abstract call for future studies to assess clinical relevance rather than asserting established utility. The only clinically useful element our copy endorses is narrower — that non-fluent aphasia in PSP and CBS 'has been clearly demonstrated in the literature and incorporated into diagnostic guidelines'. The claim's secondary clause is supported, since the review links many deficits to broader dysfunction (mental slowing/bradyphrenia, executive impairment, loss of sustained attention, frontostriatal motor network), while also noting some impairments 'appeared purely linguistic'. Overall, the review does not underscore broad clinical utility of speech and language testing; it reports that utility is unestablished. (LLM, conf=0.70)
Checked by a reasoning model — may be wrong.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“research on neurodegenerative conditions has neglected most of the world's 7000 languages.”
- Also stated in: § Introduction · plain
“Like other disciplines, 75 research on neurodegenerative conditions has neglected most of the world's 7000 languages. 76-79”
What the sources say
- Not checked yetcites [76] Blasi, 2022
- Not checked yetcites [77] Kidd, 2022, How diverse is child language acquisition research?, First Lang. source
- Partly supportedcites [78] Christiansen, 2022, Toward a comparative approach to language acquisition, Curr Dir Psychol Sci. sourceExperimental — accuracy not yet measured
The opening passage of the indexed copy states that there are more than 7,000 languages and that language sciences, especially language-acquisition research, have focused on relatively few of them. It does not address research on neurodegenerative conditions; the claim transfers the paper’s observation to a different field. (LLM, conf=0.88)
- Not checked yetcites [79] Eberhard, 2020
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the same pri mary progressive aphasia syndrome may present different symp toms depending on the patient's language.”
- Also stated in: § Speech and language dysfunctions across languages · hedged
“As long acknowledged in stroke aphasia, 108,109 the same pri mary progressive aphasia syndrome may present different symp toms depending on the patient's language.”
What the sources say
- Partly supportedcites [108] Bates, 1991, Cross-linguistic research in aphasia: An overview, Brain Lang. sourceExperimental — accuracy not yet measured
Our copy supports the general principle: the opening summary (Beverly Wulfeck, p. 1) states that crosslinguistic studies 'clearly demonstrate that the "same" aphasic syndromes look very different from one language to another,' with language differences accounting for more variance than patient-group differences, and Section II (pp. 10-12) repeats this for patient selection and test scoring. However, the paper's evidence base is Broca's and Wernicke's aphasia from focal brain injury (typically stroke; patients with history of multiple strokes or unstable onset were excluded, p. 12) — searched our copy for 'primary progressive aphasia', 'progressive', 'degenerative/dementia' and found no passage addressing that syndrome at all. So the language-dependent-presentation half of the claim is supported, but the attribution to primary progressive aphasia specifically is not. (LLM, conf=0.72)
- Not checked yetcites [109] Paradis, 2001, The need for awareness of aphasia symptoms in different languages, J Neurolinguistics. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Speech and language dysfunctions across languages · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Some of these deficits may actually occur preclini cally in each of these disorders. 3,33-36”
What the sources say
- Not checked yetcites [3] Taler, 2008, Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review, J Clin Exp Neuropsychol. source
- Not checked yetcites [33] Cuetos, 2007, Linguistic changes in verbal expression: A preclinical marker of Alzheimer's disease, J Int Neuropsychol Soc. source
- Not checked yetcites [34] Rusz, 2016, Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder, Sleep Med. source
- Partly supportedcites [35] Hlavnička, 2017, Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder, Sci Rep. sourceExperimental — accuracy not yet measured
The Discussion (conclusion paragraph) states that automated analysis of connected speech can monitor 'vocalization deficits associated with neurodegeneration based on pathological alpha-synuclein storage, from non-perceptible preclinical to more advanced dysarthria stages', and the Results/Discussion document objectively captured speech timing abnormalities (prolonged pauses, decreased rate of speech intervals) in idiopathic RBD subjects who had no perceptible speech impairment — i.e. preclinical deficits in prodromal PD. That covers the 'may occur preclinically' part for the synucleinopathy/prodromal-PD population the paper actually studied. The extension to 'each of these neurodegenerative disorders' is not demonstrated: the paper only expresses it as an expectation ('We believe that the procedure can be further elaborated and translated ... to the entire spectrum of neurodegenerative disorders manifesting motor speech disorders', and calls for future studies in other languages/biomarkers), and the deficits reported are acoustic/motor-speech features, not linguistic deficits as the paraphrase words them. (LLM, conf=0.72)
- Partly supportedcites [36] Cheran, 2019, Cognitive indicators of preclinical behavioral variant frontotemporal dementia in MAPT carriers, J Int Neuropsychol Soc. sourceExperimental — accuracy not yet measured
Our copy supports the preclinical-language part for one disorder only: the Discussion (language profiles paragraph) reports that within language, group differences emerged on semantic knowledge measures (word-picture matching, confrontation naming, semantic association, category fluency) in 12 preclinical MAPT carriers who did not meet bvFTD criteria (Abstract, Objective/Results; Discussion). The paper is confined to bvFTD arising from MAPT mutations — the Introduction notes 'relatively little work has examined the cognitive prodrome of this disorder' — so it does not establish that such linguistic deficits occur preclinically in 'each of these neurodegenerative disorders' (e.g., AD or other FTD/speech-language variants); that breadth rests on the other citations in the cluster (3, 33-36), not on this source. The only AD-related material in our copy concerns symptomatic, autopsy-confirmed patients via Rascovsky et al. (2007), not a preclinical AD comparison. (LLM, conf=0.72)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In behavioural variant frontotemporal dementia, they capture prosodic 24 and linguistic 72 alterations as well as their worsening in the course of dis ease. 57”
What the sources say
- Supportedcites [24] Nevler, 2017, Automatic measurement of prosody in behavioral variant FTD, Neurology source
The citation attached to “prosodic” supports that part of the sentence. The Abstract reports that automated speech analysis found a significantly reduced pitch range in patients with bvFTD, reflecting impaired prosody. The separate claims about linguistic alterations and worsening over the course of disease carry other citations and are not attributed to this source here. (LLM, conf=0.93)
- Supportedcites [72] Cho, 2021, Automated analysis of lexical features in frontotemporal degeneration, Cortex source
Citation 72 is attached to “linguistic alterations,” not to the separately cited claims about prosody or worsening over time. The Discussion (§5.3; page unavailable) reports that patients with behavioural variant frontotemporal dementia produced fewer adjectives than controls, demonstrating a linguistic alteration detected by the paper’s automated analysis. (LLM, conf=0.91)
- Supportedcites [57] Ash, 2019, A longitudinal study of speech production in primary progressive aphasia and behavioral variant frontotemporal dementia, Brain Lang. source
Citation 57 is attached to the claim that speech alterations worsen over the course of behavioural variant frontotemporal dementia, rather than to the separately cited prosodic and linguistic alterations. The Discussion (‘Language decline in bvFTD’; page unavailable) reports a significant decline in speech rate and in production of dependent clauses between the two time points. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
26 more claims · 11 with their cited sources checked
Create a free account to see all 71 claims and to verify the 100 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 11
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citation(2015) · HAL · Cited by 2,238
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., van Swieten, J. C., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,046
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002923 · Cited by 1,864
The Meaning of Intonational Contours in the Interpretation of Discourse
Pierrehumbert, J., & Hirschberg, J. (1990) · Intentions in Communication · doi:10.7551/mitpress/3839.003.0016 · Cited by 1,433
The worldwide costs of dementia 2015 and comparisons with 2010
Wimo, A., Guerchet, M., Ali, G., Wu, Y., Prina, A. M., Winblad, B., Jönsson, L., Liu, Z., & Prince, M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.150 · Cited by 1,066
(1990) · The MIT Press eBooks · doi:10.7551/mitpress/3839.001.0001 · Cited by 892
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70293-5 · Cited by 863
Linguistic Features Identify Alzheimer’s Disease in Narrative Speech
Fraser, K. C., Meltzer, J. A., & Rudzicz, F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150520 · Cited by 797
Cited by
Berisha, V., & Liss, J. M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01199-1 · Cited by 41
Speech patterns during memory recall relates to early tau burden across adulthood
Young, C. B., Smith, V., Karjadi, C., Grogan, S., Ang, T. F. A., Insel, P. S., Henderson, V. W., Sumner, M., Poston, K. L., Au, R., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13731 · Cited by 27
Metadata
- Authors
- García, A. M., de Leon, J., Tee, B. L., Blasi, D. E., & Gorno-Tempini, M. L.
- Affiliations
- Universidad de Santiago de Chile (CL)
- Memory and Aging Center, Department of Neurology, University of California , San Francisco, CA 94143 , USA
- University of California, San Francisco (US)
- Harvard University (US)
- Corresponding author
- García, Adolfo M
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-07-27
- Volume
- 146
- Issue
- 12
- Pages
- 4870-4879
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC10690018
- OpenAlex
- W4385295816
- Cited by
- 102
- References
- 144
- Citations by year
- 2026: 43 · 2025: 32 · 2024: 22 · 2023: 5
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Global Brain Health Institute (GBHI ALZ UK-19-589585)
- GBHI
- Alzheimer’s Association, and Alzheimer’s Society (GBHI ALZ UK-22-865742)
- FONDECYT Regular (1210176)
- Universidad de Santiago de Chile (DICYT 032351GA_DAS)
- Network of European Institutes for Advanced Study
- Programa Interdisciplinario de Investigación Experimental en Comunicación y Cognición
- USACH
- Alzheimer’s Association and National Institutes of Health (NIDCD K23 DC018021)
- Alzheimer’s Association (AACSFD-22-972143)
- National Institutes of Health (NIA R21AG068757, NIA R56-AG069130, U01 NS128913, NINDS R01 NS050915, NIDCD K24 DC015544, NIA P01 AG019724, NIA U01 AG052943, UTA 17-000879, UG3 NS105557, R01 AG038791, R01 NS100440-01, R01AG058233, U01 AG045390, U54 NS092089)
- Alzheimer’s Disease Research Center of California (P30 AG062422)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neurobiology of Language and Bilingualism
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Keywords
- neurodegeneration, speech and language assessment, cross-linguistic research, linguistic diversity, primary progressive aphasia, Alzheimer's disease, Parkinson's disease, behavioral variant frontotemporal dementia
- MeSH terms
- Alzheimer Disease, Aphasia, Humans, Language, Linguistics, Speech
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Speech and language markers of neurodegeneration: a call for global equity. https://app.cochat.ai/papers/10.1093/brain/awad253
- The paper
- García, A. M., de Leon, J., Tee, B. L., Blasi, D. E., & Gorno-Tempini, M. L. (2023). Speech and language markers of neurodegeneration: a call for global equity. Brain. https://doi.org/10.1093/brain/awad253
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.